Cost-effectiveness in Preventive Cardiology.
Cardiovascular disease remains a serious medical problem, which can be associated with death and disability on one hand, and considerable resource utilization on the other. The primary driver for choice of therapy must remain clinical efficacy. Once efficacy is established, cost-effectiveness analysis has an important role. Resources are limited, and responsible choices must be made. The methods involved in cost-effectiveness analysis are complicated and data for the analysis are generally not fully optimal. Nonetheless, cost-effectiveness analysis offers the best method for helping society make rational medical decisions. Effective interventions, when reasonably priced, for the prevention of cardiovascular disease have generally proven to be cost-effective.
Weintraub
William S.
WS
Division of Cardiology, Emory University School of Medicine, Emory Center for Outcomes Research, Briarcliff Campus, Atlanta, GA 30322, USA. wweintr@emory.edu